XML 67 R55.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Share-based compensation - Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended 12 Months Ended
Jun. 28, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Number of shares        
Options, Beginning balance   7,978,291    
Options, Granted   2,061,569    
Options, Exercised   (388,556) 0  
Options, Forfeited   (757,146)    
Options, Expired   (356,159)    
Options, Ending balance   8,537,999   7,978,291
Options, Exercisable   2,743,701    
Weighted Average Exercise price        
Beginning price   $ 6.15    
Granted   18.15    
Forfeited   8.43    
Expired   16.34    
Exercised   3.25    
Ending price   8.55   $ 6.15
Exercisable   $ 4.83    
Weighted average remaining contractual term        
Weighted Average Remaining Contractual Term   8 years 6 months 25 days   8 years 7 months 13 days
Weighted Average Remaining Contractual Term, Exercisable   7 years 2 months 12 days    
Weighted average grant date fair value   $ 13.49 $ 3.67  
Intrinsic value, outstanding   $ 46,218   $ 45,360
Intrinsic value, exercisable   23,098    
Intrinsic value, exercised   $ 5,900    
Dr. Clay Siegall | Morphimmune Inc        
Number of shares        
Options, Granted 2,137,080      
Weighted Average Exercise price        
Granted $ 5.91